Fludeoxyglucose f 18
Fludeoxyglucose f 18 is a small molecule pharmaceutical. Fludeoxyglucose f 18 was first approved as Fludeoxyglucose f18 on 1994-08-19.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Fludeoxyglucose f-18
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| FLUDEOXYGLUCOSE F18 | Feinstein Institutes for Medical Research | N-021870 RX | 2008-11-21 | 1 products, RLD, RS |
Show 3 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| fludeoxyglucose f 18 | ANDA | 2019-10-01 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
673 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | 20 | 9 | 1 | 1 | 24 | 53 | |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 9 | 11 | 1 | 1 | 26 | 47 |
| Lung neoplasms | D008175 | C34.90 | 8 | 9 | 3 | 1 | 11 | 29 | |
| Uterine cervical neoplasms | D002583 | 8 | 7 | 2 | 1 | 9 | 24 | ||
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 4 | 5 | 1 | 1 | 9 | 20 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | 2 | — | 1 | 1 | 4 |
| Dementia | D003704 | F03 | — | — | 1 | 1 | 2 | 4 | |
| Frontotemporal dementia | D057180 | G31.0 | 1 | 1 | — | 1 | — | 3 | |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 1 | 2 | 3 |
| Carotid stenosis | D016893 | — | — | — | 1 | 2 | 3 |
Show 13 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | 10 | 14 | 2 | — | 17 | 39 | ||
| Head and neck neoplasms | D006258 | 4 | 3 | 1 | — | 13 | 20 | ||
| Lymphoma | D008223 | C85.9 | 1 | 5 | 2 | — | 11 | 18 | |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 2 | 1 | — | 10 | 14 |
| Squamous cell carcinoma of head and neck | D000077195 | 3 | 4 | 1 | — | 8 | 14 | ||
| Colorectal neoplasms | D015179 | — | 1 | 2 | — | 10 | 12 | ||
| Esophageal neoplasms | D004938 | C15 | 4 | 3 | 1 | — | 3 | 10 | |
| Hodgkin disease | D006689 | C81 | 1 | 2 | 1 | — | 4 | 8 | |
| Cognitive dysfunction | D060825 | G31.84 | 1 | 1 | 2 | — | 4 | 8 | |
| Squamous cell neoplasms | D018307 | 2 | 2 | 2 | — | 1 | 6 |
Show 12 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | C61 | 5 | 3 | — | — | 12 | 20 | |
| Melanoma | D008545 | 2 | 5 | — | — | 8 | 15 | ||
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 1 | 5 | — | — | 8 | 13 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 5 | — | — | 5 | 13 |
| Glioblastoma | D005909 | EFO_0000515 | 6 | 4 | — | — | 4 | 12 | |
| Non-hodgkin lymphoma | D008228 | C85.9 | 1 | 3 | — | — | 8 | 12 | |
| Large b-cell lymphoma diffuse | D016403 | C83.3 | 3 | 1 | — | — | 8 | 11 | |
| Renal cell carcinoma | D002292 | 5 | 5 | — | — | 3 | 10 | ||
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 7 | 1 | — | — | 3 | 10 |
| Sarcoma | D012509 | 3 | 5 | — | — | 2 | 9 |
Show 83 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 6 | — | — | — | 2 | 8 |
| Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | 1 | — | — | — | 3 | 4 |
| Healthy volunteers/patients | — | 2 | — | — | — | 2 | 4 | ||
| Urologic neoplasms | D014571 | C64-C68 | 1 | — | — | — | 2 | 3 | |
| Idiopathic pulmonary fibrosis | D054990 | J84.112 | 1 | — | — | — | 2 | 3 | |
| Fallopian tube neoplasms | D005185 | 2 | — | — | — | 1 | 3 | ||
| Meningioma | D008579 | EFO_0003098 | D32.9 | 1 | — | — | — | 1 | 2 |
| Pituitary neoplasms | D010911 | 1 | — | — | — | 1 | 2 | ||
| Cholangiocarcinoma | D018281 | C22.1 | 2 | — | — | — | — | 2 | |
| Autoimmune diseases | D001327 | EFO_0000540 | M30-M36 | 1 | — | — | — | 1 | 2 |
Show 36 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Endocarditis | D004696 | EFO_0000465 | I33 | — | — | — | — | 8 | 8 |
| Positron-emission tomography | D049268 | — | — | — | — | 6 | 6 | ||
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 4 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 4 | 4 |
| Coronary artery disease | D003324 | I25.1 | — | — | — | — | 4 | 4 | |
| Infections | D007239 | EFO_0000544 | — | — | — | — | 3 | 3 | |
| Neurodegenerative diseases | D019636 | EFO_0005772 | G31.9 | — | — | — | — | 3 | 3 |
| Inflammation | D007249 | — | — | — | — | 3 | 3 | ||
| Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | — | — | 3 | 3 |
| Giant cell arteritis | D013700 | EFO_1001209 | M31.6 | — | — | — | — | 3 | 3 |
Show 106 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | FLUDEOXYGLUCOSE F 18 |
| INN | fludeoxyglucose (18f) |
| Description | 2-deoxy-2-((18)F)fluoro-alpha-D-glucose is a 2-deoxy-2-((18)F)fluoro-D-glucopyranose and a 2-deoxy-2-fluoro-alpha-D-glucose. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O |
Identifiers
| PDB | — |
| CAS-ID | 105851-17-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1092067 |
| ChEBI ID | 31617 |
| PubChem CID | 450503 |
| DrugBank | DB09150 |
| UNII ID | 0Z5B2CJX4D (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 552 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
52 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more